OncoCyte Corporation

3.03 USD
-0.85 (-21.91%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

OncoCyte Corporation stock is up 19.29% since 30 days ago. The next earnings date is Apr 3, 2023. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 7 December’s closed higher than November. 50% of analysts rate it a buy.

About OncoCyte Corporation

OncoCyte Corporation researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services.

  • Piper Sandler
    Mon Nov 13, 16:18
  • Needham
    Thu Nov 9, 11:42